'Last December, the Food and Drug Administration gave approvalto two companies, Bluebird Bio of Somerville, Mass., and Vertex Pharmaceuticals of Boston, to sell the first gene therapies approved for sickle cell disease. After nine months, Kendric remains the first Bluebird patient to progress this far, with at least a few others advancing toward his pace.'
#SickleCell #GeneTherapy
https://www.nytimes.com/2024/09/16/health/sickle-cell-gene-therapy-kendric-cromer.html